IT1298575B1 - Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di - Google Patents

Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di

Info

Publication number
IT1298575B1
IT1298575B1 IT98MI000234A ITMI980234A IT1298575B1 IT 1298575 B1 IT1298575 B1 IT 1298575B1 IT 98MI000234 A IT98MI000234 A IT 98MI000234A IT MI980234 A ITMI980234 A IT MI980234A IT 1298575 B1 IT1298575 B1 IT 1298575B1
Authority
IT
Italy
Prior art keywords
substances
antiphilic
pharmaceutical compositions
related process
nanoparticles including
Prior art date
Application number
IT98MI000234A
Other languages
English (en)
Inventor
Pierandrea Esposito
Italo Colombo
Nicoletta Coceani
Curto Maria Dorly Del
Fabio Carli
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Priority to IT98MI000234A priority Critical patent/IT1298575B1/it
Priority to CA002319565A priority patent/CA2319565A1/en
Priority to JP2000530200A priority patent/JP2002502813A/ja
Priority to EP99907510A priority patent/EP1051160A1/en
Priority to AU27238/99A priority patent/AU747129B2/en
Priority to KR1020007008610A priority patent/KR20010040726A/ko
Priority to BR9907683-7A priority patent/BR9907683A/pt
Priority to PCT/EP1999/000782 priority patent/WO1999039700A1/en
Publication of ITMI980234A1 publication Critical patent/ITMI980234A1/it
Application granted granted Critical
Publication of IT1298575B1 publication Critical patent/IT1298575B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
IT98MI000234A 1998-02-06 1998-02-06 Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di IT1298575B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT98MI000234A IT1298575B1 (it) 1998-02-06 1998-02-06 Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
CA002319565A CA2319565A1 (en) 1998-02-06 1999-02-05 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
JP2000530200A JP2002502813A (ja) 1998-02-06 1999-02-05 脂質物質及び両親媒性物質より成っているナノ粒子の形態の薬学的組成物と関連する調製工程
EP99907510A EP1051160A1 (en) 1998-02-06 1999-02-05 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
AU27238/99A AU747129B2 (en) 1998-02-06 1999-02-05 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
KR1020007008610A KR20010040726A (ko) 1998-02-06 1999-02-05 지질성 물질 및 양친매성 물질을 포함하는 나노입자형태의 약학적 조성물 및 관련 제조방법
BR9907683-7A BR9907683A (pt) 1998-02-06 1999-02-05 Composições farmacêuticas na forma de nanopartìculas, compreendendo substâncias lipìdicas e substâncias anfifìlicas e processo de preparação correlacionado
PCT/EP1999/000782 WO1999039700A1 (en) 1998-02-06 1999-02-05 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000234A IT1298575B1 (it) 1998-02-06 1998-02-06 Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di

Publications (2)

Publication Number Publication Date
ITMI980234A1 ITMI980234A1 (it) 1999-08-06
IT1298575B1 true IT1298575B1 (it) 2000-01-12

Family

ID=11378856

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000234A IT1298575B1 (it) 1998-02-06 1998-02-06 Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di

Country Status (8)

Country Link
EP (1) EP1051160A1 (it)
JP (1) JP2002502813A (it)
KR (1) KR20010040726A (it)
AU (1) AU747129B2 (it)
BR (1) BR9907683A (it)
CA (1) CA2319565A1 (it)
IT (1) IT1298575B1 (it)
WO (1) WO1999039700A1 (it)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
EP1214928A4 (en) * 1999-08-18 2004-03-24 Kyowa Hakko Kogyo Kk HAIR GROWTH FUNDS
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
IL149378A0 (en) * 1999-11-01 2002-11-10 Rodeva Ltd Composition for treatment of constipation and irritable bowel syndrome
CN1406140A (zh) * 2000-02-28 2003-03-26 吉倪塞思公司 纳米胶囊包封系统与方法
ATE389455T1 (de) 2000-05-10 2008-04-15 Jagotec Ag Zerkleinerung mittels mahlkörper
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
KR100508695B1 (ko) * 2001-02-13 2005-08-17 한국과학기술연구원 인슐린의 경구투여용 제형과 그의 제조방법
WO2002098366A2 (en) * 2001-06-07 2002-12-12 University Of Kentucky Research Foundation Nanoscintillation systems for aqueous-based liquid scintillation counting
KR100593861B1 (ko) * 2001-09-24 2006-06-30 한국과학기술원 칼시토닌을 함유한 경구투여용 나노입자의 제조방법
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
IL160570A0 (en) * 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
ITMI20012599A1 (it) 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
JP4251988B2 (ja) * 2001-12-14 2009-04-08 ヤーゴテック アクチェンゲゼルシャフト シクロスポリンを含む医薬製剤およびその使用
SE0104421D0 (sv) 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
KR100422763B1 (ko) * 2002-01-17 2004-03-12 주식회사 태평양 경피흡수 촉진 능력이 우수한 식물성 나노입자의 제조 및이를 함유하는 화장료 및 의약용 외용제 조성물
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
KR100507771B1 (ko) * 2002-11-08 2005-08-17 한미약품 주식회사 난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
KR20040084240A (ko) * 2003-03-27 2004-10-06 (주) 코스메디 고형지질나노입자, 이를 함유하는 활성성분 전달용약학조성물 및 이의 제조방법
US7438903B2 (en) 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
WO2005016386A1 (en) * 2003-08-19 2005-02-24 Meditech Research Limited Improved therapeutic protocols
EP1684725A1 (en) * 2003-10-31 2006-08-02 Elan Pharma International Limited Novel nimesulide compositions
EP1691795A2 (en) * 2003-12-03 2006-08-23 LifeCycle Pharma A/S Pharmaceutical compositions comprising danazol
US7803366B2 (en) 2004-05-07 2010-09-28 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
EP1674077A1 (en) * 2004-12-27 2006-06-28 Université de Liège Mucoadhesive pharmaceutical compositions comprising chemoattractants
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8252326B2 (en) 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2086513B1 (en) * 2006-09-26 2016-09-07 Samyang Biopharmaceuticals Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
KR20100020459A (ko) 2007-06-08 2010-02-22 아드레넥스 파마슈티컬스, 아이엔씨. 지연 방출형 제제 및 아드레날린 조절부전의 치료방법
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
FR2943545B1 (fr) * 2009-03-31 2011-06-03 Univ Claude Bernard Lyon Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.
WO2011037623A1 (en) 2009-09-28 2011-03-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
FR2958150B1 (fr) 2010-04-01 2012-06-15 Univ Claude Bernard Lyon Elements orthodontiques elastiques aptes a liberer de la chlorhexidine faiblement soluble dans la salive
CN102247320B (zh) * 2010-05-21 2013-03-13 天津药物研究院 一种依托泊苷长循环乳剂及其制备方法
BRPI1002601E2 (pt) * 2010-06-01 2020-06-30 Embrapa Pesquisa Agropecuaria composição nanoestruturada de uso veterinário para administração de fármacos
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
FR2995222B1 (fr) * 2012-09-11 2016-05-20 Creathes Procede alternatif de microencapsulation de principe actif
EP2919767B1 (en) * 2012-11-14 2020-04-01 Abon Pharmaceuticals, LLC Oral transmucosal drug delivery system
CN102988285B (zh) * 2012-12-13 2014-02-19 哈药集团技术中心 一种多西他赛注射液组合物及其制备方法
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2014282762B2 (en) 2013-06-20 2016-11-10 Ichnos Sciences SA Nanoparticulate formulation comprising a TRPA1 antagonist
EP2821077A1 (en) 2013-07-04 2015-01-07 Praxis Biopharma Research Institute Lipid nanoparticles for wound healing
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
EP3154528B1 (en) 2014-06-11 2023-04-05 SpecGx LLC Spray dried compositions having different dissolution profiles and processes for their preparation
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
DK3174535T3 (da) * 2014-08-01 2019-05-13 Glenmark Pharmaceuticals Sa Nanopartikelformulering, der omfatter en mpges-1-hæmmer
US10987308B2 (en) 2014-09-03 2021-04-27 Genesegues, Inc. Therapeutic nanoparticles and related compositions, methods and systems
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
WO2021016134A1 (en) * 2019-07-19 2021-01-28 Spi Pharma, Inc. Preparation of lipophilic active ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof

Also Published As

Publication number Publication date
CA2319565A1 (en) 1999-08-12
BR9907683A (pt) 2000-11-14
EP1051160A1 (en) 2000-11-15
ITMI980234A1 (it) 1999-08-06
AU2723899A (en) 1999-08-23
WO1999039700A1 (en) 1999-08-12
KR20010040726A (ko) 2001-05-15
JP2002502813A (ja) 2002-01-29
AU747129B2 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
IT1298575B1 (it) Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
PT1107777E (pt) Composicao farmaceutica estabilizada na forma liofilizada
ATE374603T1 (de) Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation
CY2007013I1 (el) Νεες συνταγοποιησεις αγωνιστου εξεντινης και μεθοδοι χορηγησης αυτων
DE60138768D1 (de) Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
DE69829017D1 (de) Hydrophob modifiziertes Polysaccharid in Körperpflegeprodukten
ITMI20001732A0 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
IT1296464B1 (it) Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69903282D1 (de) Elektrostatisches beschichtungsverfahren und dadurch erhaltene beschichtete produkte
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
ITMI950711A0 (it) Composizione efficace nella rimozione degli asfalteni
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
HUP0300917A3 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them
IT1291710B1 (it) Metodo ed apparecchiatura per la preparazione di film monostrato di particelle o molecole.
IT1304190B1 (it) Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
FI20002768A (fi) Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
ITMI20000553A0 (it) Derivati di condensazione ad attivita' antitumorale loro metodo di preparazione e formulazioni che li contengono
FI973607A0 (fi) Metod och arrangemang foer stoedning av motstaondstraodarnas aendar i tillverkning av med el vaermesvetsbara plastroerens foerbindningsdelar i en formsprutningsform
DE69930804D1 (de) Herstellung von schwefelarmen Platin-Schichten und Platinaluminid-Schichten in thermischen Sperrschichten
ITMI20011687A0 (it) Processo per la preparazione in emulsione di particelle polimeriche composite
PT1216021E (pt) Composicoes farmaceuticas e/ou cosmeticas
FR2846237B1 (fr) Composition sous forme d'emulsion huile-dans-eau et ses utilisations notamment cosmetiques
IT1298613B1 (it) Chelati complessi di manganese ad alta relassivita' in siero

Legal Events

Date Code Title Description
0001 Granted